Advertisement
Screener

Regenicin, Inc. Debt Conversion, Converted Instrument, Rate

Regenicin, Inc. Debt Conversion, Converted Instrument, Rate

Regenicin, Inc. reported Debt Conversion, Converted Instrument, Rate of 8.00% for the 6-month period ending 2023-03-31, per its 10-Q filed 2023-05-15.

Discontinued › Cash Flow › Financing Activities

us-gaap:DebtConversionConvertedInstrumentRate · last filed 2023-05-15

  • Regenicin, Inc. debt conversion, converted instrument, rate for the quarter ending 2022-12-31 was 8.00%, a 0.00% change year-over-year.
  • Regenicin, Inc. debt conversion, converted instrument, rate for the quarter ending 2021-12-31 was 8.00%.
Period endDebt Conversion, Converted Instrument, Rate 3 monthDebt Conversion, Converted Instrument, Rate 6 monthDebt Conversion, Converted Instrument, Rate 9 month
2023-03-318.00%
10-Q · filed 2023-05-15
2022-12-318.00%
10-Q · filed 2023-02-13
2022-06-308.00%
10-Q · filed 2022-08-12
2022-03-318.00%
10-Q · filed 2022-05-23
2021-12-318.00%
10-Q/A · filed 2022-03-25